2022-23 U.S. Seasonal Influenza Vaccine Overview
Key Points: COVID In today’s Recommendation for Industry, we discuss 2022-23 U.S. Seasonal Influenza Vaccine Overview. Read more below. Paxlovid, molnupiravir benefit older COVID-19 patients,
Key Points: COVID In today’s Recommendation for Industry, we discuss 2022-23 U.S. Seasonal Influenza Vaccine Overview. Read more below. Paxlovid, molnupiravir benefit older COVID-19 patients,
Intended to help consumers easily identify any bioengineered (BE) ingredients in foods, the USDA BE foods labeling standard, which became mandatory this year, is carrying
A recent study commissioned by the Food Standards Agency (FSA) of the UK found that not only do many aspects of Canada’s food safety system
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to
Over the last year, thousands of products have been recalled in Europe due to the presence of ethylene oxide (EtO) or its breakdown products, particularly
Key Points: COVID In today’s Recommendation for Industry, we discuss flu season in the Southern Hemisphere. Read more below. Serious adverse events rare after COVID-19
If the research and development efforts of the National Institute of Standards and Technology (NIST) pan out, the U.S. could soon have a roadside test
TAG Expands Assessments to Include Current Communicable Disease Data Key Points: COVID In today’s Recommendation for Industry, we discuss TAG expanding our public health offerings
Key Points: In today’s Recommendation for Industry, we discuss the “why” behind testing at Day 6 if you’ve been exposed and testing multiple times for
Reports of mishandling and illness from breaded stuffed raw chicken products go back nearly as far as the availability of the product itself. Since 1998,